drugset / Trial / NCT01388829

Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532

NCT01388829

Phase 1 Completed 10 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

This study is designed to compare the pharmacokinetics of two different lots of tablets.

Timeline

Start
2011-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04991532 Small molecule 150 mg

Indications

No indication recorded.